Tenax Therapeutics
TENX
15 hedge funds and large institutions have $6.54M invested in Tenax Therapeutics in 2022 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 1 closing their positions.
0% more ownership
Funds ownership: 0.02% → 0.02% (+0%)
6% less funds holding
Funds holding: 16 → 15 (-1)
22% less capital invested
Capital invested by funds: $8.38M → $6.54M (-$1.84M)
50% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 4
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IC
Ikarian Capital
Dallas,
Texas
|
+$27.8K |
| 2 |
State Street
Boston,
Massachusetts
|
+$2.23K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$8.91K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$3.34K |
| 3 |
BlackRock
New York
|
-$1.11K |
| 4 |
HF
HRT Financial
New York
|
-$1.11K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.11K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
GG
1
Gofen & Glossberg
Chicago,
Illinois
| $3.09M | – | – | – |
|
|
AC
2
Armistice Capital
New York
| $1.64M | – | – | – |
|
|
IC
3
Ikarian Capital
Dallas,
Texas
| $596K | +$27.8K | +25 | +6% |
|
|
4
BlackRock
New York
| $413K | -$1.11K | -1 | -0.3% |
|
|
5
Vanguard Group
Malvern,
Pennsylvania
| $290K | -$1.11K | -1 | -0.4% |
|
6
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $162K | – | – | – |
|
|
7
State Street
Boston,
Massachusetts
| $112K | +$2.23K | +2 | +2% |
|
|
BFM
8
Boothbay Fund Management
New York
| $58K | – | – | – |
|
|
9
Renaissance Technologies
New York
| $55K | -$8.91K | -8 | -16% |
|
|
FWP
10
FAS Wealth Partners
Leawood,
Kansas
| $47K | – | – | – |
|
11
Geode Capital Management
Boston,
Massachusetts
| $41K | – | – | – |
|
12
Northern Trust
Chicago,
Illinois
| $28K | – | – | – |
|
|
HF
13
HRT Financial
New York
| $8K | -$1.11K | -1 | -13% |
|
|
TRCT
14
Tower Research Capital (TRC)
New York
| $4K | – | – | – |
|
|
BCV
15
Banque Cantonale Vaudoise
Lausanne,
Switzerland
| $1K | – | – | – |
|
|
16
UBS Group
Zurich,
Switzerland
| – | -$3.34K | -3 | Closed |
|
TENX Hedge Fund Activity: Q1 2022 in Review
15 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Tenax Therapeutics (TENX) for Q1 2022, worth a combined $6.54M — down 22% from $8.38M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of TENX and 0 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 2 added.
The largest buyer was Ikarian Capital, adding an estimated $27.8K. The largest seller was Renaissance Technologies, cutting an estimated $8.91K.
- 15 institutional investors held Tenax Therapeutics (TENX) as of Q1 2022, down from 16 in Q4 2021.
- Funds reported $6.54M of Tenax Therapeutics stock for Q1 2022, down 22% quarter-over-quarter.
- 0 funds opened new Tenax Therapeutics positions in Q1 2022 and 1 closed out, a net change of -1 holder.
- The largest Tenax Therapeutics buyer in Q1 2022 was Ikarian Capital, an estimated $27.8K added.
- The largest Tenax Therapeutics seller in Q1 2022 was Renaissance Technologies, an estimated $8.91K sold.
Based on aggregated 13F filings for Q1 2022.